Elevate your local knowledge
Sign up for the iNFOnews newsletter today!
Valeant Pharma promises to do better with deadlines
Shares of Valeant Pharmaceuticals are sharply higher after the embattled drug company promised to do better with financial filing deadlines.
It’s a problem that had some debt holders declaring the company in default earlier this year.
The Canadian company also reiterated first-quarter earnings guidance of $1.30 to $1.55 per share Monday.
Valeant will file its first-quarter statement with regulators several weeks before deadline. It also expects to submit future quarterly filings on time.
Valeant posted long-overdue results from 2015 late last month as it wrestles with a number of government investigations and a plunging stock price.
Shares of Valeant Pharmaceuticals International Inc. climbed 3 per cent, or 96 cents, to $30.82 in early trading.
News from © The Associated Press, . All rights reserved.
This material may not be published, broadcast, rewritten or redistributed.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Join the Conversation!
Want to share your thoughts, add context, or connect with others in your community?
You must be logged in to post a comment.
